Therapy-resistant tibial pseudarthrosis: Treatment success with BMP-7 combined with autologous bone;Therapieresistente Unterschenkelpseudarthrose: Behandlungserfolg durch BMP-7, Kombiniert mit Autologem Knochen

Unfallchirurg

Volumn 113, Issue 1, 2010, Pages 59-64

  Siebenlist, S ^a   Kraus, T ^a   Burghardt, R ^a   Dobele S ^a   Stockle U ^a   Ganslmeier, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone morphogenetic protein 7 (BMP 7); Non union; Risk factors; Tibial fracture

Indexed keywords

BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN 1 PUTTY, RECOMBINANT HUMAN;

ARTICLE; BONE TRANSPLANTATION; CASE REPORT; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSEUDARTHROSIS; TIBIA FRACTURE; TREATMENT FAILURE; TREATMENT OUTCOME;

BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; PSEUDARTHROSIS; TIBIAL FRACTURES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77149160359     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-009-1673-3     Document Type: Article

References (16)

1. Littenberg B, Weinstein LP, McCarren M, et al. (1998) Closed fractures of the tibial shaft. A meta-analysis of three methods of treatment. J Bone Joint Surg [Am] 80:174-183
2. Green E, Lubahn JD, Evans J (2005) Risk factors, treatment, and outcomes associated with nonunion of the midshaft humerus fracture. J Surg Orthop Adv 14(2):64-72
3. Hayda RA, Brighton CT, Esterhai JL (1998) Patho-physiology of delayed healing. Clin Orthop Relat Res 219:206-213
4. Cook SD, Baffes GC, Wolfe MW, et al. (1994) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect. Clin Orthop Relat Res 301:302-312
5. Grauer JN, Patel TC, Erulkar JS, et al. (2001) Evaluati- on of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 26:127-133
6. Reddi AH (2001) Bone morphogenetic proteins: from basic science to clinical approaches. J Bone Joint Surg [Am] 83-A [suppl 1]:1-6
7. Sakou T (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22:591-603
8. Friedlaender GE, Perry CR, Colle JD, et al. (2001) Os- teogenetic protein-1 (bone morphogenetic prote- in-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am] 83 [suppl 1]:151-158
9. Zimmermann G, Müller U, Löffler C, et al. (2007) Therapeutic outcome in tibial pseudarthrosis. Bo- ne morphogenetic protein-7 (BMP-7) versus auto- logous bone grafting for tibial fractures. Unfallchir- urg 110(2):931-938
10. Zimmermann G, Moghaddam A, Wagner C, et al. (2006) Clinical experience with bone morphoge- netic protein 7 (BMP 7) in nonunions of long bo- nes. Unfallchirurg 109(7):528-537
11. Govender S, Csimma C, Genannt HK, et al. (2002) Recombinant human bone morphogenetic pro- tein-2 for treatment of open tibial fractures: a pro- spective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 84-A:127-133
12. Kenwright J, Gardner T (1998) Mechanical influ- ences on tibial fracture healing. Clin Orthop Relat Res 355 [suppl]:179-190
13. Jupiter JB, Ring D, Rosen H (1995) The complica- tions and difficulties of management of nonunion in the severely obese. J Orthop Trauma 9(5):363- 370 14.
14. Mason EE, Renquist KE, Jiang D (1992) Periopera- tive risks and safety of surgery for severe obesity. Am J Clin Nutr 55 [suppl]:573-576
15. Kanakaris NK, Calori GM, Verdonk R, et al. (2008) Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 39 [suppl 2]:83-90
16. Desmyter S, Goubau Y, Verdonk R, et al. (2008) The role of bone morphogenetic protein-7 (osteogenic protein-1) in the treatment of tibial fracture non- unions. An overview of the use in Belgium. Acta Orthop Belg 74(4):534-537